Joslyn S. Kirby

Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States

Amit Garg, Joslyn S. Kirby, Jonathan Lavian et al. · JAMA Dermatology · 2017 · 371 citations · Full text

Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project

Amit Garg, Erica Neuren, Denny Cha et al. · Journal of the American Academy of Dermatology · 2019 · 268 citations · Full text

Health Policy, Global Survey, Patient Safety +7

A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process

Linnea Thorlacius, John R Ingram, Bente Villumsen et al. · British Journal of Dermatology · 2018 · 165 citations · Full text

Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa

Falk G. Bechara, Maurizio Podda, Errol P. Prens et al. · JAMA Surgery · 2021 · 141 citations · Full text

Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials

Alexa B. Kimball, Gregor B. E. Jemec, Christopher J. Sayed et al. · The Lancet · 2024 · 128 citations · Full text

Moderate-to-severe Hidradenitis Suppurativa, Be Heard Ii, Be Heard +3